- Report
- August 2025
- 189 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 191 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 197 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 199 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 182 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 190 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- July 2025
- 218 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- May 2025
- 200 Pages
Global
From €2217EUR$2,490USD£1,937GBP
- Report
- June 2025
- 193 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- October 2025
- 365 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 378 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 181 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 267 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 180 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 182 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 288 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 466 Pages
Global
From €5208EUR$5,850USD£4,550GBP
- Report
- October 2025
- 287 Pages
Global
From €5208EUR$5,850USD£4,550GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more